Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Starpharma Holdings Limited (AU: SPL)

 
SPL Technical Analysis
5
As on 3rd Dec 2025 SPL STOCK Price closed @ 0.36 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.13 & Strong Buy for SHORT-TERM with Stoploss of 0.11 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

SPLSTOCK Price

Open 0.38 Change Price %
High 0.38 1 Day -0.03 -7.69
Low 0.36 1 Week -0.03 -7.69
Close 0.36 1 Month 0.04 12.50
Volume 267017 1 Year 0.26 260.00
52 Week High 0.44 | 52 Week Low 0.09
 
AU Australia Most Active Stocks
OVT 0.00 %
PET 0.03 %
LKE 0.08 0.00%
IVR 0.08 14.29%
RML 0.06 0.00%
NTU 0.03 %
PDI 0.73 17.74%
ERA 0.00 %
NSR 2.70 -0.37%
CXO 0.22 0.00%
 
AU Australia Top Gainers Stocks
APV 0.02 100.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
HIO 0.03 50.00%
QFE 0.08 33.33%
HGO 0.04 33.33%
 
AU Australia Top Losers Stocks
TEM 0.00 -100.00%
TEM 0.00 -100.00%
TEM 0.00 -100.00%
TEM 0.00 -100.00%
TEM 0.00 -100.00%
WLD 0.01 -50.00%
TAS 0.02 -33.33%
TAS 0.02 -33.33%
LMG 0.02 -33.33%
LMG 0.02 -33.33%
 
 
SPL
Daily Charts		 SPL
Intraday Charts		 Whats New @
Bazaartrend		 SPL
Free Analysis
 
SPL Important Levels Intraday
RESISTANCE0.40
RESISTANCE0.39
RESISTANCE0.38
RESISTANCE0.37
SUPPORT0.35
SUPPORT0.34
SUPPORT0.33
SUPPORT0.32
 
SPL Forecast December 2025
Share
4th UP Forecast0.42
3rd UP Forecast0.4
2nd UP Forecast0.39
1st UP Forecast0.38
1st DOWN Forecast0.34
2nd DOWN Forecast0.33
3rd DOWN Forecast0.32
4th DOWN Forecast0.3
 
SPL Weekly Forecast
4th UP Forecast0.40
3rd UP Forecast0.39
2nd UP Forecast0.38
1st UP Forecast0.37
1st DOWN Forecast0.35
2nd DOWN Forecast0.34
3rd DOWN Forecast0.33
4th DOWN Forecast0.32
 
SPL Forecast2025
4th UP Forecast1.05
3rd UP Forecast0.83
2nd UP Forecast0.69
1st UP Forecast0.56
1st DOWN Forecast0.16
2nd DOWN Forecast0.03
3rd DOWN Forecast-0.11
4th DOWN Forecast-0.33
 
 
SPL Other Details
Segment EQ
Market Capital 434674688.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
SPL Address
SPL
 
SPL Latest News
 
Your Comments and Response on Starpharma Holdings Limited
 
SPL Business Profile
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia. Address: 4-6 Southampton Crescent, Abbotsford, VIC, Australia, 3067
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service